Index RUT
P/E 23.71
EPS (ttm) 0.95
Insider Own 13.84%
Shs Outstand 103.41M
Perf Week -2.26%
Market Cap 2.33B
Forward P/E 21.97
EPS next Y 1.02
Insider Trans -1.19%
Shs Float 89.19M
Perf Month -8.84%
Income 105.47M
PEG -
EPS next Q 0.22
Inst Own 80.52%
Short Float 23.68%
Perf Quarter -1.71%
Sales 482.38M
P/S 4.82
EPS this Y 8.51%
Inst Trans 2.20%
Short Ratio 17.77
Perf Half Y -17.50%
Book/sh 4.90
P/B 4.59
EPS next Y 0.33%
ROA 17.51%
Short Interest 21.12M
Perf Year -0.09%
Cash/sh 3.56
P/C 6.32
EPS next 5Y -
ROE 20.92%
52W Range 20.84 - 34.28
Perf YTD -30.79%
Dividend Est. -
P/FCF 18.34
EPS past 5Y 9.67%
ROI 20.82%
52W High -34.41%
Beta 0.51
Dividend TTM -
Quick Ratio 4.31
Sales past 5Y 14.14%
Gross Margin 98.66%
52W Low 7.87%
ATR (14) 1.08
Dividend Ex-Date -
Current Ratio 4.39
EPS Y/Y TTM 7.91%
Oper. Margin 22.24%
RSI (14) 40.57
Volatility 5.86% 4.10%
Employees 352
Debt/Eq 0.00
Sales Y/Y TTM 20.04%
Profit Margin 21.87%
Recom 1.00
Target Price 42.80
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 97.33%
Payout 0.00%
Rel Volume 0.00
Prev Close 22.48
Sales Surprise 4.75%
EPS Surprise 8.49%
Sales Q/Q 31.39%
Earnings Feb 15 AMC
Avg Volume 1.19M
Price 22.48
SMA20 -6.58%
SMA50 -5.72%
SMA200 -15.40%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-06-23 Upgrade
Truist
Hold → Buy
$29 → $38
Apr-11-23 Initiated
SVB Securities
Market Perform
$25
Apr-04-23 Initiated
Piper Sandler
Overweight
$27
Feb-15-23 Downgrade
Jefferies
Buy → Hold
$35 → $22
Aug-01-22 Downgrade
Truist
Buy → Hold
$30
Jul-27-22 Upgrade
Jefferies
Hold → Buy
$21 → $35
Jun-27-22 Resumed
Canaccord Genuity
Buy
$30 → $34
Feb-02-22 Initiated
Canaccord Genuity
Buy
$30
Jan-28-22 Initiated
Truist
Buy
$30
Aug-05-20 Downgrade
Jefferies
Buy → Hold
$16
Sep-24-19 Initiated
Jefferies
Buy
$20
Sep-06-19 Initiated
H.C. Wainwright
Buy
$18
Feb-04-19 Downgrade
B. Riley FBR
Buy → Neutral
$22 → $12
Aug-10-18 Reiterated
Stifel
Hold
$20 → $11
May-31-18 Downgrade
Stifel
Buy → Hold
$20
Mar-09-18 Initiated
B. Riley FBR, Inc.
Buy
$30
Aug-31-17 Initiated
Stifel
Buy
$20
Feb-02-17 Initiated
Ladenburg Thalmann
Buy
$14
Apr-21-15 Initiated
FBR Capital
Outperform
$12
Jan-13-14 Downgrade
Stifel
Buy → Hold
Show Previous Ratings
Apr-24-24 04:05PM
Apr-23-24 12:12PM
Apr-22-24 08:00AM
Apr-17-24 12:00PM
Apr-16-24 11:34AM
08:00AM
Loading…
Apr-15-24 08:00AM
Apr-09-24 11:09AM
Apr-08-24 08:00AM
Apr-01-24 08:00AM
Mar-25-24 10:20AM
Feb-16-24 01:33PM
09:04AM
08:57AM
(Thomson Reuters StreetEvents)
Feb-15-24 04:47PM
(Associated Press Finance)
04:44PM
04:07PM
Loading…
04:07PM
04:02PM
Feb-14-24 02:41AM
Feb-08-24 04:05PM
Jan-29-24 12:10PM
08:00AM
Jan-09-24 10:48AM
Jan-08-24 08:00AM
Jan-04-24 09:04AM
Jan-02-24 02:29PM
12:13PM
(Associated Press Finance)
11:27AM
08:00AM
Dec-29-23 06:43PM
06:34PM
06:14PM
Loading…
06:14PM
Dec-24-23 09:01AM
Dec-08-23 09:50AM
Dec-06-23 11:05PM
Dec-01-23 11:31AM
Nov-09-23 10:01PM
Nov-04-23 07:03AM
Nov-02-23 02:39PM
11:23AM
Nov-01-23 06:18PM
04:42PM
(Associated Press Finance)
04:05PM
08:00AM
Oct-31-23 08:40AM
Oct-26-23 04:05PM
10:02AM
Oct-25-23 04:05PM
Oct-16-23 09:45AM
09:26AM
Oct-12-23 11:29AM
10:42AM
Oct-10-23 10:24AM
07:44AM
Oct-04-23 09:32AM
Oct-03-23 10:08AM
Sep-29-23 08:00AM
Sep-28-23 10:48AM
Sep-26-23 09:36AM
Sep-22-23 07:58AM
Sep-19-23 01:22PM
Sep-18-23 08:52AM
08:29AM
Sep-12-23 08:26AM
Sep-08-23 11:30AM
Sep-07-23 12:17PM
11:41AM
11:30AM
Sep-06-23 11:30AM
Sep-01-23 11:31AM
Aug-31-23 11:02AM
Aug-30-23 11:09AM
Aug-29-23 09:40AM
Aug-28-23 10:45AM
Aug-25-23 11:51AM
08:10AM
Aug-24-23 09:54AM
Aug-22-23 11:56AM
10:18AM
Aug-21-23 11:12AM
Aug-10-23 12:20PM
11:50AM
Aug-04-23 12:34PM
Aug-03-23 11:48AM
Aug-02-23 05:35PM
04:28PM
04:05PM
Jul-26-23 04:05PM
10:02AM
Jul-17-23 04:05PM
Jul-03-23 09:37AM
Jun-27-23 08:00AM
Jun-21-23 08:00PM
Jun-09-23 11:30AM
Jun-07-23 09:15AM
Jun-02-23 11:31AM
May-04-23 03:29PM
11:23AM
(Thomson Reuters StreetEvents)
May-03-23 05:25PM
04:18PM
04:05PM
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MAHONEY DAVID L Director Apr 10 '24 Option Exercise 1.74 30,000 52,200 30,000 Apr 12 07:00 PM Lyon Joseph Douglas See Remarks Apr 04 '24 Option Exercise 11.35 5,443 61,778 12,757 Apr 08 06:16 PM Lyon Joseph Douglas See Remarks Apr 04 '24 Sale 26.00 5,443 141,524 7,314 Apr 08 06:16 PM Swisher Daniel N JR Director Apr 01 '24 Option Exercise 5.86 2,200 12,892 2,200 Apr 03 07:38 PM Lyon Joseph Douglas See Remarks Apr 01 '24 Option Exercise 11.35 500 5,675 7,814 Apr 03 08:00 PM Swisher Daniel N JR Director Apr 01 '24 Sale 25.30 2,200 55,660 0 Apr 03 07:38 PM Lyon Joseph Douglas See Remarks Apr 01 '24 Sale 26.01 500 13,004 7,314 Apr 03 08:00 PM Maduck Sean See Remarks Mar 27 '24 Option Exercise 3.88 25,953 100,698 111,175 Mar 29 02:12 PM Maduck Sean See Remarks Mar 27 '24 Sale 25.01 25,953 649,025 85,222 Mar 29 02:12 PM Maduck Sean See Remarks Mar 19 '24 Option Exercise 2.61 10,000 26,100 85,222 Mar 20 05:09 PM Maduck Sean See Remarks Mar 18 '24 Option Exercise 3.88 17,219 66,810 92,441 Mar 20 05:09 PM Maduck Sean See Remarks Mar 18 '24 Sale 25.00 17,219 430,475 75,222 Mar 20 05:09 PM Swisher Daniel N JR Director Mar 01 '24 Option Exercise 5.86 2,200 12,892 2,200 Mar 05 09:02 PM Swisher Daniel N JR Director Mar 01 '24 Sale 23.59 2,200 51,898 0 Mar 05 09:02 PM Maduck Sean See Remarks Feb 16 '24 Option Exercise 3.61 27,068 97,810 101,523 Feb 20 08:06 PM Lyon Joseph Douglas Chief Accounting Officer Feb 16 '24 Option Exercise 11.35 1,000 11,350 7,774 Feb 21 09:11 PM Maduck Sean See Remarks Feb 16 '24 Sale 25.97 27,068 702,905 74,455 Feb 20 08:06 PM Lyon Joseph Douglas Chief Accounting Officer Feb 16 '24 Sale 26.00 1,000 26,000 6,774 Feb 21 09:11 PM Maduck Sean See Remarks Feb 15 '24 Option Exercise 3.29 4,760 15,660 79,215 Feb 20 08:06 PM Maduck Sean See Remarks Feb 15 '24 Sale 25.00 4,760 119,000 74,455 Feb 20 08:06 PM Swisher Daniel N JR Director Feb 01 '24 Option Exercise 5.86 2,200 12,892 2,200 Feb 02 05:39 PM Swisher Daniel N JR Director Feb 01 '24 Sale 22.00 2,200 48,400 0 Feb 02 05:39 PM Hunt Hazel Chief Scientific Officer Jan 08 '24 Option Exercise 3.02 50,000 151,000 123,146 Jan 12 08:06 PM Swisher Daniel N JR Director Jan 02 '24 Option Exercise 5.86 2,200 12,892 2,200 Jan 04 07:14 PM Swisher Daniel N JR Director Jan 02 '24 Sale 22.11 2,200 48,642 0 Jan 04 07:14 PM Guyer William Chief Development Officer Dec 22 '23 Option Exercise 19.26 10,000 192,600 16,643 Dec 22 07:29 PM Guyer William Chief Development Officer Dec 22 '23 Sale 32.00 10,000 320,000 6,643 Dec 22 07:29 PM Robb Gary Charles Chief Business Officer Dec 06 '23 Sale 27.01 6,212 167,786 21,390 Dec 06 08:56 PM Robb Gary Charles Chief Business Officer Dec 05 '23 Sale 26.27 1,381 36,277 27,602 Dec 06 08:56 PM Robb Gary Charles Chief Business Officer Dec 04 '23 Option Exercise 3.29 15,000 49,350 37,771 Dec 06 08:56 PM Lyon Joseph Douglas Chief Accounting Officer Dec 04 '23 Option Exercise 11.35 2,432 27,603 8,286 Dec 05 06:59 PM Lyon Joseph Douglas Chief Accounting Officer Dec 04 '23 Sale 26.00 2,432 63,232 5,854 Dec 05 06:59 PM Maduck Sean See Remarks Dec 01 '23 Option Exercise 3.02 25,000 75,444 98,291 Dec 05 06:58 PM Lyon Joseph Douglas Chief Accounting Officer Dec 01 '23 Option Exercise 11.35 2,568 29,147 8,422 Dec 05 06:59 PM Swisher Daniel N JR Director Dec 01 '23 Option Exercise 5.86 2,200 12,892 2,200 Dec 05 07:00 PM Maduck Sean See Remarks Dec 01 '23 Sale 25.56 25,000 639,048 73,291 Dec 05 06:58 PM Lyon Joseph Douglas Chief Accounting Officer Dec 01 '23 Sale 26.00 2,568 66,768 5,854 Dec 05 06:59 PM Swisher Daniel N JR Director Dec 01 '23 Sale 25.47 2,200 56,034 0 Dec 05 07:00 PM Maduck Sean See Remarks Nov 02 '23 Option Exercise 2.61 19,888 51,908 93,179 Nov 03 06:32 PM Lyon Joseph Douglas Chief Accounting Officer Nov 02 '23 Option Exercise 11.35 3,977 45,139 9,831 Nov 03 06:49 PM Maduck Sean See Remarks Nov 02 '23 Sale 28.11 19,888 559,056 73,291 Nov 03 06:32 PM Lyon Joseph Douglas Chief Accounting Officer Nov 02 '23 Sale 28.11 3,977 111,794 5,854 Nov 03 06:49 PM Maduck Sean See Remarks Nov 01 '23 Option Exercise 2.61 5,112 13,342 78,403 Nov 03 06:32 PM Swisher Daniel N JR Director Nov 01 '23 Option Exercise 5.86 2,200 12,892 2,200 Nov 03 06:14 PM Lyon Joseph Douglas Chief Accounting Officer Nov 01 '23 Option Exercise 11.35 1,023 11,611 6,877 Nov 03 06:49 PM Maduck Sean See Remarks Nov 01 '23 Sale 28.08 5,112 143,545 73,291 Nov 03 06:32 PM Swisher Daniel N JR Director Nov 01 '23 Sale 27.96 2,200 61,512 0 Nov 03 06:14 PM Lyon Joseph Douglas Chief Accounting Officer Nov 01 '23 Sale 28.08 1,023 28,726 5,854 Nov 03 06:49 PM Maduck Sean See Remarks Oct 10 '23 Option Exercise 2.80 18,471 51,682 92,081 Oct 12 08:19 PM Maduck Sean See Remarks Oct 10 '23 Sale 27.29 18,471 504,038 73,291 Oct 12 08:19 PM Lyon Joseph Douglas Chief Accounting Officer Oct 06 '23 Option Exercise 11.35 2,582 29,306 8,436 Oct 10 05:26 PM Maduck Sean See Remarks Oct 06 '23 Option Exercise 3.02 3,498 10,564 77,108 Oct 10 05:36 PM Maduck Sean See Remarks Oct 06 '23 Sale 27.24 3,498 95,286 73,610 Oct 10 05:36 PM Lyon Joseph Douglas Chief Accounting Officer Oct 06 '23 Sale 27.24 2,582 70,334 5,854 Oct 10 05:26 PM Lyon Joseph Douglas Chief Accounting Officer Oct 02 '23 Option Exercise 11.35 2,418 27,444 8,272 Oct 04 04:19 PM Swisher Daniel N JR Director Oct 02 '23 Option Exercise 5.86 2,200 12,892 2,200 Oct 04 04:19 PM Maduck Sean See Remarks Oct 02 '23 Option Exercise 3.02 3,031 9,154 76,641 Oct 04 04:05 PM Maduck Sean See Remarks Oct 02 '23 Sale 27.24 3,031 82,577 73,610 Oct 04 04:05 PM Lyon Joseph Douglas Chief Accounting Officer Oct 02 '23 Sale 27.25 2,418 65,889 5,854 Oct 04 04:19 PM Swisher Daniel N JR Director Oct 02 '23 Sale 27.32 2,200 60,104 0 Oct 04 04:19 PM Maduck Sean See Remarks Sep 19 '23 Sale 32.48 25,000 812,000 73,610 Sep 20 06:07 PM Robb Gary Charles Chief Business Officer Sep 19 '23 Sale 32.74 5,000 163,677 21,996 Sep 20 06:06 PM Maduck Sean See Remarks Sep 18 '23 Option Exercise 3.02 25,000 75,500 98,610 Sep 20 06:07 PM Robb Gary Charles Chief Business Officer Sep 14 '23 Option Exercise 3.29 13,963 45,938 34,992 Sep 18 06:12 PM Swisher Daniel N JR Director Sep 05 '23 Option Exercise 5.86 2,200 12,892 2,200 Sep 06 07:04 PM Swisher Daniel N JR Director Sep 05 '23 Sale 32.90 2,200 72,380 0 Sep 06 07:04 PM Lyon Joseph Douglas Chief Accounting Officer Sep 01 '23 Option Exercise 11.35 5,000 56,750 10,132 Sep 06 06:21 PM Swisher Daniel N JR Director Sep 01 '23 Option Exercise 6.55 1,550 10,152 1,550 Sep 06 07:04 PM Lyon Joseph Douglas Chief Accounting Officer Sep 01 '23 Sale 32.73 5,000 163,650 5,132 Sep 06 06:21 PM Swisher Daniel N JR Director Sep 01 '23 Sale 32.73 1,550 50,731 0 Sep 06 07:04 PM Lyon Joseph Douglas Chief Accounting Officer Aug 21 '23 Option Exercise 8.83 4,588 40,508 9,720 Aug 22 06:24 PM Lyon Joseph Douglas Chief Accounting Officer Aug 21 '23 Sale 31.19 4,588 143,100 5,132 Aug 22 06:24 PM MAHONEY DAVID L Director Aug 14 '23 Sale 30.95 25,000 773,668 11,297 Aug 16 04:53 PM Hunt Hazel Chief Scientific Officer Aug 14 '23 Sale 30.89 20,455 631,753 73,146 Aug 15 04:09 PM Hunt Hazel Chief Scientific Officer Aug 08 '23 Option Exercise 3.02 50,000 151,000 123,146 Aug 09 06:15 PM Swisher Daniel N JR Director Aug 07 '23 Option Exercise 6.39 2,850 18,219 2,850 Aug 09 03:07 PM Lyon Joseph Douglas Chief Accounting Officer Aug 07 '23 Option Exercise 8.27 412 3,407 5,132 Aug 09 05:20 PM Swisher Daniel N JR Director Aug 07 '23 Sale 30.14 2,850 85,909 0 Aug 09 03:07 PM Lyon Joseph Douglas Chief Accounting Officer Aug 07 '23 Sale 31.22 412 12,863 4,720 Aug 09 05:20 PM Maduck Sean See Remarks Jul 17 '23 Option Exercise 1.92 10,000 19,200 72,698 Jul 19 04:30 PM Lyon Joseph Douglas Chief Accounting Officer Jun 06 '23 Option Exercise 11.35 10,000 113,500 15,132 Jun 07 09:17 PM Lyon Joseph Douglas Chief Accounting Officer Jun 06 '23 Sale 23.60 10,000 236,000 5,132 Jun 07 09:17 PM Robb Gary Charles Chief Business Officer May 10 '23 Sale 24.07 14,000 336,980 19,997 May 11 07:30 PM Robb Gary Charles Chief Business Officer May 09 '23 Sale 23.87 30,000 716,100 33,997 May 11 07:30 PM MAHONEY DAVID L Director May 08 '23 Option Exercise 1.74 30,000 52,200 1,239,275 May 09 04:45 PM Robb Gary Charles Chief Business Officer May 05 '23 Option Exercise 2.70 105,000 283,800 124,583 May 09 04:45 PM
Index RUT
P/E -
EPS (ttm) -0.21
Insider Own 5.14%
Shs Outstand 181.25M
Perf Week 1.22%
Market Cap 300.92M
Forward P/E -
EPS next Y -0.05
Insider Trans -3.72%
Shs Float 171.96M
Perf Month -5.14%
Income -37.49M
PEG -
EPS next Q -0.05
Inst Own 78.86%
Short Float 3.44%
Perf Quarter -7.78%
Sales 156.37M
P/S 1.92
EPS this Y 47.30%
Inst Trans -0.34%
Short Ratio 3.69
Perf Half Y 29.69%
Book/sh 0.29
P/B 5.71
EPS next Y 55.00%
ROA -18.03%
Short Interest 5.92M
Perf Year -32.52%
Cash/sh 0.36
P/C 4.57
EPS next 5Y -
ROE -62.35%
52W Range 1.21 - 3.08
Perf YTD -23.15%
Dividend Est. -
P/FCF -
EPS past 5Y 13.81%
ROI -29.71%
52W High -46.10%
Beta 1.31
Dividend TTM -
Quick Ratio 1.55
Sales past 5Y 16.80%
Gross Margin 54.84%
52W Low 37.76%
ATR (14) 0.12
Dividend Ex-Date -
Current Ratio 2.14
EPS Y/Y TTM 13.94%
Oper. Margin -36.30%
RSI (14) 38.76
Volatility 5.31% 6.54%
Employees 288
Debt/Eq 1.82
Sales Y/Y TTM -3.51%
Profit Margin -23.98%
Recom 1.67
Target Price 4.20
Option/Short Yes / Yes
LT Debt/Eq 1.40
EPS Q/Q 90.49%
Payout -
Rel Volume 0.00
Prev Close 1.66
Sales Surprise -0.42%
EPS Surprise 63.64%
Sales Q/Q 6.21%
Earnings May 02 AMC
Avg Volume 1.60M
Price 1.66
SMA20 -5.68%
SMA50 -16.22%
SMA200 -12.54%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-12-24 Initiated
Craig Hallum
Buy
$5
Jan-20-23 Downgrade
BTIG Research
Buy → Neutral
Jan-17-23 Downgrade
Stephens
Overweight → Equal-Weight
$3.75
Oct-08-20 Resumed
BTIG Research
Buy
$9
Jun-16-20 Resumed
Cantor Fitzgerald
Overweight
$9
Feb-26-20 Initiated
BTIG Research
Buy
$7
Nov-13-19 Upgrade
BTIG Research
Neutral → Buy
$7
Aug-28-19 Initiated
Stifel
Buy
Aug-23-19 Resumed
Stephens
Overweight
Jan-05-18 Resumed
Cantor Fitzgerald
Overweight
Dec-08-17 Resumed
BTIG Research
Neutral
Jul-07-16 Resumed
Cantor Fitzgerald
Buy
$9
Dec-17-15 Downgrade
Wedbush
Outperform → Neutral
May-02-14 Reiterated
MLV & Co
Buy
$8.50 → $6
Apr-24-13 Reiterated
Cantor Fitzgerald
Buy
$5.50 → $6
Mar-15-13 Reiterated
MLV & Co
Buy
$7.50 → $8.50
Apr-17-12 Initiated
Cantor Fitzgerald
Buy
$5.50
Feb-29-12 Upgrade
Robert W. Baird
Neutral → Outperform
$3 → $6
Nov-10-11 Reiterated
MLV & Co
Buy
$4 → $5
Jun-03-11 Initiated
Wedbush
Outperform
$4
Show Previous Ratings
Apr-18-24 08:30AM
Mar-26-24 08:30AM
Mar-19-24 08:00AM
Mar-15-24 01:49AM
01:48AM
01:40PM
Loading…
Mar-07-24 01:40PM
11:46AM
Mar-06-24 06:23AM
(Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM
04:26PM
(Associated Press Finance)
04:00PM
Feb-23-24 11:56AM
Feb-20-24 08:30AM
Feb-01-24 08:30AM
Jan-15-24 09:30AM
08:30AM
Loading…
Jan-08-24 08:30AM
Nov-03-23 09:19AM
08:30AM
Nov-02-23 06:43PM
05:25PM
04:20PM
(Associated Press Finance)
04:00PM
Oct-19-23 08:30AM
Oct-10-23 08:30AM
Sep-27-23 08:30AM
Sep-12-23 08:30AM
Aug-02-23 05:15PM
04:11PM
(Associated Press Finance)
04:00PM
Jul-31-23 12:36PM
08:30AM
Loading…
Jul-19-23 08:30AM
Jul-03-23 05:13PM
Jun-15-23 08:30AM
Jun-14-23 08:30AM
Jun-07-23 10:30AM
Jun-05-23 08:30AM
May-30-23 07:16AM
May-04-23 05:15PM
04:10PM
04:00PM
May-02-23 12:25PM
Apr-20-23 08:30AM
Apr-18-23 10:54AM
Mar-10-23 09:24AM
Mar-09-23 11:45AM
Feb-28-23 04:00PM
Feb-21-23 11:00AM
Feb-15-23 08:30AM
Feb-10-23 08:30AM
Jan-19-23 11:45AM
Jan-09-23 08:30AM
Dec-21-22 05:50AM
Nov-09-22 05:58AM
Nov-04-22 08:00AM
Nov-03-22 05:55PM
04:00PM
Nov-02-22 01:52PM
Nov-01-22 08:00AM
Oct-20-22 08:30AM
Sep-26-22 08:00AM
Sep-21-22 09:35AM
Sep-14-22 11:55AM
Sep-13-22 11:17AM
Aug-29-22 09:35AM
Aug-24-22 07:58AM
Aug-12-22 08:00AM
Aug-05-22 01:00PM
Aug-04-22 05:25PM
04:00PM
Jul-28-22 09:48AM
Jul-21-22 08:00AM
Jul-14-22 12:00PM
06:25AM
Jul-13-22 11:37AM
Jul-05-22 05:00PM
Jun-23-22 09:55AM
Jun-14-22 08:00AM
Jun-03-22 09:55AM
May-17-22 05:00AM
May-16-22 09:55AM
May-15-22 08:42AM
May-06-22 02:30AM
May-05-22 05:15PM
04:00PM
May-03-22 08:00AM
Apr-28-22 08:35AM
Apr-25-22 08:00AM
Apr-21-22 08:00AM
Apr-07-22 11:39AM
Feb-25-22 08:00AM
Feb-23-22 10:00AM
Feb-22-22 10:00PM
04:01PM
Feb-08-22 08:00AM
Feb-07-22 04:05PM
Feb-04-22 05:36AM
Jan-28-22 01:38PM
Jan-10-22 08:00AM
Dec-28-21 10:00AM
Dec-06-21 04:43AM
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Greenman William Mariner President and CEO Mar 14 '24 Sale 2.02 63,611 128,195 3,181,281 Mar 14 09:30 PM Jayaraman Vivek K Chief Operating Officer Mar 14 '24 Sale 1.97 26,794 52,902 878,653 Mar 14 09:33 PM Green Kevin Dennis Chief Financial Officer Mar 14 '24 Sale 1.97 21,497 42,444 618,750 Mar 14 09:53 PM Jensen Chrystal Chief Legal Officer Mar 14 '24 Sale 1.97 17,824 35,192 490,912 Mar 14 09:47 PM Benjamin Richard J Chief Medical Officer Mar 14 '24 Sale 1.97 17,738 35,022 459,612 Mar 14 09:15 PM CORASH LAURENCE M Chief Scientific Officer Mar 14 '24 Sale 1.97 14,360 28,352 2,339,740 Mar 14 09:22 PM Greenman William Mariner President and CEO Mar 13 '24 Sale 2.06 62,315 128,182 3,244,892 Mar 14 09:30 PM Jayaraman Vivek K Chief Operating Officer Mar 13 '24 Sale 2.06 26,247 53,990 905,447 Mar 14 09:33 PM Green Kevin Dennis Chief Financial Officer Mar 13 '24 Sale 2.02 21,058 42,438 640,247 Mar 14 09:53 PM Moore Carol SVP Reg. & Quality Mar 13 '24 Sale 2.02 20,619 41,553 490,623 Mar 14 09:49 PM Jensen Chrystal Chief Legal Officer Mar 13 '24 Sale 2.06 17,460 35,915 508,736 Mar 14 09:47 PM Benjamin Richard J Chief Medical Officer Mar 13 '24 Sale 2.06 17,377 35,744 477,350 Mar 14 09:15 PM CORASH LAURENCE M Chief Scientific Officer Mar 13 '24 Sale 2.06 14,067 28,936 2,354,100 Mar 14 09:22 PM Benjamin Richard J Chief Medical Officer Mar 08 '24 Sale 2.40 29,378 70,457 478,061 Mar 12 06:10 PM BJERKHOLT ERIC Director Dec 13 '23 Buy 1.62 10,000 16,200 142,133 Dec 13 05:55 PM Lucena Ann Director Aug 22 '23 Buy 1.69 7,500 12,638 72,284 Aug 23 06:11 PM BJERKHOLT ERIC Director Aug 21 '23 Buy 1.72 10,000 17,151 132,133 Aug 23 06:08 PM Swisher Daniel N JR Director May 26 '23 Buy 1.91 5,000 9,535 118,808 May 30 03:45 PM SCHULZE GAIL Director May 24 '23 Buy 2.03 9,850 19,981 83,420 May 24 07:18 PM BJERKHOLT ERIC Director May 23 '23 Buy 2.00 5,000 10,000 82,133 May 23 05:57 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite